Expect more barriers - prior authorization, documented BMI thresholds, proof of failed lifestyle interventions, or outright exclusion
For people who achieve better results on tirzepatide, this compounded alternative makes the more effective medication accessible
Some research suggests that individuals who have lost significant weight may experience lower metabolic rates than predicted for their new body size, though this varies considerably between individuals
The difficulties this caused is highlighted by Marks
For some patients, a GLP-1 or related medication may be appropriate
Our model combines highquality compounding, licensed physician oversight, unlimited telehealth checkins, and personalized dosing to make semaglutide therapy accessible, affordable, and convenientno insurance required